The Synergistic Cytotoxic Effect of Pentagamavunon-1 (PGV-1) and Curcumin Correlates with the Cell Cycle Arrest to Induce Mitotic Catastrophe in 4T1 and T47D Breast Cancer Cells

Desty Restia Rahmawati; Arief Nurrochmad; Riris Istighfari Jenie; Edy Meiyanto

doi:10.18585/inabj.v15i5.2594

The Synergistic Cytotoxic Effect of Pentagamavunon-1 (PGV-1) and Curcumin Correlates with the Cell Cycle Arrest to Induce Mitotic Catastrophe in 4T1 and T47D Breast Cancer Cells

Desty Restia Rahmawati, Arief Nurrochmad, Riris Istighfari Jenie, Edy Meiyanto

Abstract

BACKGROUND: The anti-cancer properties of pentagamavunon-1 (PGV-1) and curcumin have been documented. This study aimed to evaluate the cytotoxic effect of this combination on breast cancer cell growth using 4T1 and T47D cells, representing triple-negative breast cancer (TNBC) and non-TNBC, respectively.

METHODS: Cytotoxic assay was evaluated using MTT reagent for single and combination treatment of PGV-1 and curcumin in 4T1 and T47D cells. Cell cycle analysis was examined through flowcytometry with propidium iodide dye. May Grünwald-Giemsa staining was also performed to analyze the mitotic catastrophe

RESULTS: PGV-1 and curcumin alone had significant cytotoxic effects against two breast cancer cell lines, with IC50 values of 4 μM and 40 μM for 4T1 and 2 μM and 20 μM for T47D, respectively. Both compounds showed high selectivity for the 4T1 and T47D cells (selectivity index >3). In addition, when PGV-1 and curcumin were combined, a synergistic effect was observed in both cell types with a combination index of <0.7. This combination results in cell cycle arrest in the G2/M phase, increased cell accumulation in the sub-G1 phase, and a synergistic increase in mitotic catastrophe.

CONCLUSION: Combined intervention of PGV-1 and curcumin on TNBC and non-TNBC breast cancer cells substantially augments cell cycle arrest in the G2/M and sub-G1 phases, coupled with the occurrence of mitotic catastrophe. In summary, the results suggest that PGV-1 coupled with curcumin holds promise as an effective approach to addressing breast cancer and warrants further investigation.

KEYWORDS: 4T1 cells, T47D cells, breast cancer, curcumin, mitotic catastrophe, PGV-1

Full Text:

PDF

References

Lestari B, Nakamae I, Yoneda-Kato N, Morimoto T, Kanaya S, Yokoyama T, et al. Pentagamavunon-1 (PGV-1) inhibits ROS metabolic enzymes and suppresses tumor cell growth by inducing M phase (prometaphase) arrest and cell senescence. Sci Rep. 2019; 9(1): 14867, CrossRef.

Pujimulyani D, Yulianto WA, Setyawati A, Rizal R, Qodariah RL, Khoiriyah Z, et al. Curcuma mangga Val. extract as antidiabetic agent in 3T3-L1 adipocyte cells. Mol Cell Biomed Sci. 2020; 4(1): 45-51, CrossRef.

Shankar S, Srivastava RK. Bax and Bak genes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa. Carcinogenesis. 2007; 28(6): 1277-86, CrossRef.

Meiyanto E, Septisetyani EP, Larasati YA, Kawaichi M. Curcumin analog pentagamavunon-1 (PGV-1) sensitizes Widr cells to 5-fluorouracil through inhibition of NF-κB activation. Asian Pac J Cancer Prev. 2018; 19(1): 49-56, CrossRef.

Meiyanto E, Putri DD, Susidarti RA, Murwanti R, Sardjiman, Fitriasari A, et al. Curcumin and its analogues (PGV-0 and PGV-1) enhance sensitivity of resistant MCF-7 cells to doxorubicin through inhibition of HER2 and NF-kB activation. Asian Pac J Cancer Prev. 2014; 15(1): 179-84, CrossRef.

Novitasari D, Jenie RI, Utomo RY, Kato JY, Meiyanto E. CCA-1.1, a novel curcumin analog, exerts cytotoxic anti-migratory activity toward TNBC and HER2-enriched breast cancer cells. Asian Pac J Cancer Prev. 2021; 22(6): 1827-36, CrossRef.

Wulandari F, Kirihata M, Kato JY, Meiyanto E. Curcumin analogs, PGV-1 and CCA-1.1 exhibit anti-migratory effects and suppress MMP9 expression on WiDr cells. Indones Biomed J. 2021; 13(3): 271-80, CrossRef.

Larasati YA, Yoneda-Kato N, Nakamae I, Yokoyama T, Meiyanto E, Kato JY. Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth. Sci Rep. 2018; 8(1): 2039, CrossRef.

Scott SJ, Li X, Jammula S, Devonshire G, Lindon C, Fitzgerald RC, et al. Evidence that polyploidy in esophageal adenocarcinoma originates from mitotic slippage caused by defective chromosome attachments. Cell Death Differ. 2021; 28(7): 2179-93, CrossRef.

Feillet C, van der Horst GT, Levi F, Rand DA, Delaunay F. Coupling between the circadian clock and cell cycle oscillators: Implication for healthy cells and malignant growth. Front Neurol. 2015; 6: 96, CrossRef.

Blagosklonny MV, Pardee AB. The restriction point of the cell cycle. Cell Cycle. 2002; 1(2): 103-10, PMID.

Endah E, Wulandari F, Putri Y, Jenie RI, Meiyanto E. Piperine increases pentagamavunon-1 anti-cancer activity on 4T1 breast cancer through mitotic catastrophe mechanism and senescence with sharing targeting on mitotic regulatory proteins. Iran J Pharm Res. 2022; 21(1): e123820, CrossRef.

Musyayyadah H, Wulandari F, Nangimi AF, Anggraeni AD, Ikawati M, Meiyanto E. The growth suppression activity of diosmin and PGV-1 co-treatment on 4T1 breast cancer targets mitotic regulatory proteins. Asian Pac J Cancer Prev. 2021; 22(9): 2929-38, CrossRef.

Hasbiyani NA, Wulandari F, Nugroho EP, Hermawan A, Meiyanto E. Bioinformatics analysis confirms the target protein underlying mitotic catastrophe of 4T1 cells under combinatorial treatment of PGV-1 and galangin. Sci Pharm. 2021; 89(3): 38, CrossRef.

Bracci L, Schiavoni G, Sistigu A, Belardelli F. Immune-based mechanisms of cytotoxic chemotherapy: Implications for the design of novel and rationale-based combined treatments against cancer. Cell Death Differ. 2014; 21(1): 15-25, CrossRef.

Barrios CH. Global challenges in breast cancer detection and treatment. Breast. 2022; 62 Suppl 1(Suppl 1): S3-6, CrossRef.

Aresta G, Araújo T, Kwok S, Chennamsetty SS, Safwan M, Alex V, et al. BACH: Grand challenge on breast cancer histology images. Med Image Anal. 2019; 56: 122-39, CrossRef.

Han HS, Vikas P, Costa RLB, Jahan N, Taye A, Stringer-Reasor EM. Early-stage triple-negative breast cancer journey: Beginning, end, and everything in between. Am Soc Clin Oncol Educ Book. 2023; 43: e390464, CrossRef.

Onitilo AA, Engel JM, Greenlee RT, Mukesh BN. Breast cancer subtypes based on ER/PR and Her2 expression: Comparison of clinicopathologic features and survival. Clin Med Res. 2009; 7(1-2): 4-13, CrossRef.

Ghasemi M, Turnbull T, Sebastian S, Kempson I. The MTT assay: Utility, limitations, pitfalls, and interpretation in bulk and single-cell analysis. Int J Mol Sci. 2021; 22(23): 12827, CrossRef.

Freimoser FM, Jakob CA, Aebi M, Tuor U. The MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay is a fast and reliable method for colorimetric determination of fungal cell densities. Appl Environ Microbiol. 1999; 65(8): 3727-9, CrossRef.

Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010; 70(2): 440-6, CrossRef.

Meiyanto E, Husnaa U, Kastian RF, Putri H, Larasati YA, Khumaira A, et al. The target differences of anti-tumorigenesis potential of curcumin and its analogues against HER-2 positive and triple-negative breast cancer cells. Adv Pharm Bull. 2021; 11(1): 188-96, CrossRef.

Meiyanto E, Putri H, Larasati YA, Utomo RY, Jenie RI, Ikawati M, et al. Anti-proliferative and anti-metastatic potential of curcumin analogue, pentagamavunon-1 (PGV-1), toward highly metastatic breast cancer cells in correlation with ROS generation. Adv Pharm Bull. 2019; 9(3): 445-52, CrossRef.

Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G. Cell death by mitotic catastrophe: A molecular definition. Oncogene. 2004; 23(16): 2825-37, CrossRef.

Sazonova EV, Petrichuk SV, Kopeina GS, Zhivotovsky B. A link between mitotic defects and mitotic catastrophe: Detection and cell fate. Biol Direct. 2021; 16(1): 25, CrossRef.

Ogrodnik M. Cellular aging beyond cellular senescence: Markers of senescence prior to cell cycle arrest in vitro and in vivo. Aging Cell. 2021; 20(4): e13338, CrossRef.

Al-Mahmood S, Sapiezynski J, Garbuzenko OB, Minko T. Metastatic and triple-negative breast cancer: Challenges and treatment options. Drug Deliv Transl Res. 2018; 8(5): 1483-507, CrossRef.

Gupta SC, Patchva S, Koh W, Aggarwal BB. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol. 2012; 39(3): 283-99, CrossRef.

Troselj KG, Kujundzic RN. Curcumin in combined cancer therapy. Curr Pharm Des. 2014; 20(42): 6682-96, CrossRef.

Yu S, Kim T, Yoo KH, Kang K. The T47D cell line is an ideal experimental model to elucidate the progesterone-specific effects of a luminal A subtype of breast cancer. Biochem Biophys Res Commun. 2017; 486(3): 752-8, CrossRef.

Wei LL, Miner R. Evidence for the existence of a third progesterone receptor protein in human breast cancer cell line T47D. Cancer Res. 1994; 54(2): 340-3, PMID.

DOI: https://doi.org/10.18585/inabj.v15i5.2594

Copyright (c) 2023 The Prodia Education and Research Institute